Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 80.5% in December

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,550,100 shares, an increase of 80.5% from the December 15th total of 858,900 shares. Based on an average trading volume of 900 shares, the days-to-cover ratio is presently 1,722.3 days.

Ascentage Pharma Group International Stock Performance

ASPHF opened at $6.45 on Friday. The stock’s 50 day simple moving average is $6.45 and its 200 day simple moving average is $4.37. Ascentage Pharma Group International has a 1 year low of $6.45 and a 1 year high of $6.45.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.